Evidence map›Paper›PMID 29181870›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2018

Lithium-Catalyzed Thiol Alkylation with Tertiary and Secondary Alcohols: Synthesis of 3-Sulfanyl-Oxetanes as Bioisosteres.

Rosemary A Croft, James J Mousseau, Chulho Choi, James A Bull

Open access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Synthesis ofThe Journal of organic chemistry · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Synthesis of 3,3-Disubstituted Thietane Dioxides.The Journal of organic chemistry · 2024
    Article
  9. Oxetanes in Drug Discovery Campaigns.Journal of medicinal chemistry · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. From Propargylic Alcohols to Substituted Thiochromenes:The Journal of organic chemistry · 2021
    Article
  16. Review
  17. B(CRSC advances · 2018
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Rosemary A CroftDepartment of Chemistry, Imperial College London, South Kensington, London, SW7 2AZ, UK.ORCID http://orcid.org/0000-0002-0571-3187
James J MousseauPfizer Medicine Design, Eastern Point Road, Groton, CT, 06340, USA.
Chulho ChoiPfizer Medicine Design, Eastern Point Road, Groton, CT, 06340, USA.
James A BullDepartment of Chemistry, Imperial College London, South Kensington, London, SW7 2AZ, UK.ORCID http://orcid.org/0000-0003-3993-5818
Imperial College London · GBPfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

3-Sulfanyl-oxetanes are presented as promising novel bioisosteric replacements for thioesters or benzyl sulfides. From oxetan-3-ols, a mild and inexpensive Li catalyst enables chemoselective C-OH activation and thiol alkylation. Oxetane sulfides are formed from various thiols providing novel motifs in new chemical space and specifically as bioisosteres for thioesters due to their similar shape and electronic properties. Under the same conditions, various π-activated secondary and tertiary alcohols are also successful. Derivatization of the oxetane sulfide linker provides further novel oxetane classes and building blocks. Comparisons of key physicochemical properties of the oxetane compounds to selected carbonyl and methylene analogues indicate that these motifs are suitable for incorporation into drug discovery efforts.

Indexed as

AlcoholsAlkylationCysteineSulfhydryl CompoundsSulfidesSulfonesAlcoholsCysteineSulfhydryl CompoundsSulfidesSulfonesbioisostereshomogeneous catalysisoxetanesoxygen heterocyclessulfides

Identifiers

PMID29181870
PMCPMC5814735
OpenAlexW2768305881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.